Bruce G. Allen Investments’s Charles River Laboratories CRL Stock Holding History

Bruce G. Allen Investments’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.3K	Hold	226	–	–	0.03%	266
2026 Q1	$39K	Sell	226 -2	-0.9%	-$371	0.03%	306
2025 Q4	$45.5K	Sell	228 -13	-5%	-$2.36K	0.03%	268
2025 Q3	$37.7K	Sell	241 -2	-0.8%	-$318	0.03%	308
2025 Q2	$36.9K	Sell	243 -3	-1%	-$400	0.03%	298
2025 Q1	$37K	Sell	246 -17	-6%	-$2.85K	0.03%	300
2024 Q4	$48.5K	Sell	263 -9	-3%	-$1.73K	0.04%	264
2024 Q3	$53.6K	Sell	272 -1	-0.4%	-$208	0.04%	251
2024 Q2	$56.4K	Sell	273 -42	-13%	-$9.52K	0.05%	221
2024 Q1	$85.3K	Buy	315 +21	+7%	+$5.01K	0.07%	172
2023 Q4	$69.5K	Buy	+294	New	+$57.8K	0.06%	185

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Bruce G. Allen Investments's CRL Position: Q2 2026 in Review

Bruce G. Allen Investments held its Charles River Laboratories (CRL) position steady in Q2 2026 at 226 shares worth $51.3K. The position accounts for 0.03% of the portfolio, ranked #266.

Bruce G. Allen Investments first reported a position in CRL in Q4 2023 and has held it in 11 quarters since. The position peaked at $85.3K in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Bruce G. Allen Investments held 226 shares of Charles River Laboratories worth $51.3K as of Q2 2026.
Bruce G. Allen Investments left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up 0.03% of Bruce G. Allen Investments's portfolio in Q2 2026, its #266 holding.
Bruce G. Allen Investments first reported a position in Charles River Laboratories in Q4 2023 and has held it in 11 quarters since.
Bruce G. Allen Investments's Charles River Laboratories position peaked at $85.3K in Q1 2024.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.